Kentucky Retirement Systems Regeneron Pharmaceuticals, Inc. Transaction History

Kentucky Retirement Systems

  • $3.35 Billion
  • Q3 2024

A detailed history of Kentucky Retirement Systems transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kentucky Retirement Systems holds 7,393 shares of REGN stock, worth $5.6 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
7,393
Previous 7,993 7.51%
Holding current value
$5.6 Million
Previous $8.4 Million 7.49%
% of portfolio
0.23%
Previous 0.25%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$1024.09 - $1201.76 $614,454 - $721,056
-600 Reduced 7.51%
7,393 $7.77 Million
Q2 2024

Aug 12, 2024
SELL
$883.2 - $1071.19 $26,496 - $32,135
-30 Reduced 0.37%
7,993 $8.4 Million
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $494,674 - $544,355
-548 Reduced 6.39%
8,023 $7.72 Million
Q4 2023

Feb 08, 2024
BUY
$775.18 - $881.7 $65,890 - $74,944
85 Added 1.0%
8,571 $7.53 Million
Q3 2023

Oct 12, 2023
SELL
$692.45 - $844.37 $130,873 - $159,585
-189 Reduced 2.18%
8,486 $6.98 Million
Q2 2023

Aug 07, 2023
BUY
$700.03 - $830.35 $122,505 - $145,311
175 Added 2.06%
8,675 $6.23 Million
Q1 2023

May 10, 2023
BUY
$680.49 - $826.97 $49,675 - $60,368
73 Added 0.87%
8,500 $6.98 Million
Q4 2022

Feb 06, 2023
BUY
$705.89 - $766.39 $25,412 - $27,590
36 Added 0.43%
8,427 $6.08 Million
Q3 2022

Nov 16, 2022
BUY
$573.97 - $724.32 $214,090 - $270,171
373 Added 4.65%
8,391 $5.78 Million
Q2 2022

Aug 08, 2022
BUY
$548.35 - $738.84 $666,793 - $898,429
1,216 Added 17.88%
8,018 $4.74 Million
Q1 2022

May 09, 2022
SELL
$595.12 - $698.43 $55,941 - $65,652
-94 Reduced 1.36%
6,802 $4.75 Million
Q4 2021

Feb 04, 2022
BUY
$543.48 - $670.97 $428,262 - $528,724
788 Added 12.9%
6,896 $4.36 Million
Q3 2021

Nov 17, 2021
BUY
$574.03 - $680.96 $6,314 - $7,490
11 Added 0.18%
6,108 $3.7 Million
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $69,974 - $82,663
-148 Reduced 2.37%
6,097 $3.41 Million
Q1 2021

May 14, 2021
SELL
$446.73 - $548.2 $33,504 - $41,115
-75 Reduced 1.19%
6,245 $2.96 Million
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $112,878 - $143,483
236 Added 3.88%
6,320 $3.05 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $255,487 - $308,700
469 Added 8.35%
6,084 $3.41 Million
Q2 2020

Aug 12, 2020
BUY
$493.32 - $643.92 $78,437 - $102,383
159 Added 2.91%
5,615 $3.5 Million
Q1 2020

May 01, 2020
BUY
$336.18 - $494.43 $452,498 - $665,502
1,346 Added 32.75%
5,456 $2.66 Million
Q4 2019

Feb 18, 2020
BUY
$274.13 - $376.51 $4,111 - $5,647
15 Added 0.37%
4,110 $1.54 Million
Q3 2019

Nov 05, 2019
BUY
$273.46 - $318.39 $118,408 - $137,862
433 Added 11.82%
4,095 $1.14 Million
Q2 2019

Aug 07, 2019
BUY
$299.6 - $414.82 $70,406 - $97,482
235 Added 6.86%
3,662 $1.15 Million
Q1 2019

May 22, 2019
BUY
$372.08 - $439.57 $18,976 - $22,418
51 Added 1.51%
3,427 $1.41 Million
Q4 2018

Feb 25, 2019
BUY
$335.82 - $403.04 $25,522 - $30,631
76 Added 2.3%
3,376 $1.26 Million
Q3 2018

Nov 19, 2018
SELL
$351.14 - $408.51 $1.12 Million - $1.3 Million
-3,184 Reduced 49.11%
3,300 $0
Q3 2018

Nov 16, 2018
BUY
$351.14 - $408.51 $1.12 Million - $1.31 Million
3,200 Added 97.44%
6,484 $0
Q2 2018

Aug 13, 2018
SELL
$284.6 - $344.99 $212,311 - $257,362
-746 Reduced 18.51%
3,284 $1.13 Million
Q1 2018

May 07, 2018
SELL
$315.82 - $393.78 $227,706 - $283,915
-721 Reduced 15.18%
4,030 $1.39 Million
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $25,821 - $33,836
72 Added 1.54%
4,751 $1.79 Million
Q3 2017

Nov 08, 2017
SELL
$431.38 - $504.0 $88,864 - $103,824
-206 Reduced 4.22%
4,679 $2.09 Million
Q2 2017

Aug 18, 2017
BUY
N/A
4,885
4,885 $2.4 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Kentucky Retirement Systems Portfolio

Follow Kentucky Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email